So far this past week was a busy one for those at the FDA's device office focused on mobile medical app regulation. No, it didn't release its final guidance document yet, even though Congress gave the agency a verbal lashing more than three months ago now. Still, the agency has had an unusually busy week.
Apart from the typical -- like Rock Health alum Nephosity securing FDA 510(k) clearance for...
